COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,003 Articles (22,627 medRxiv, 8,376 bioRxiv)

Most recent first Previous |  Page 383: Articles 3821-3830  | Next

Towards Pandemic-Scale Ancestral Recombination Graphs of SARS-CoV-2
Zhan, S. H., Ignatieva, A., Wong, Y., Eaton, K., Jeffery, B., Palmer, D. S., Murall, C. L., Otto, S., Kelleher, J.
10.1101/2023.06.08.544212 — Posted: 2023-06-08
An evolutionarily conserved strategy for ribosome binding and inhibition by β-coronavirus non-structural protein 1
Maurina, S. F., O'Sullivan, J. P., Sharma, G., Pineda Rodriguez, D. C., MacFadden, A., Cendali, F., Henen, M. A., Kieft, J. S., Glasgow, A., Steckelberg, A.-L.
10.1101/2023.06.07.544141 — Posted: 2023-06-08
Single-cell RNA sequencing reveals HIF1A as a severity-sensitive immunological scar in circulating monocytes of convalescent comorbidity-free COVID-19 patients
Zielinski, C., May, L., Chu, C.-F.
10.1101/2023.06.07.544062 — Posted: 2023-06-08
Anti-Viral and Anti-Inflammatory Therapeutic Effect of RAGE-Ig Protein Against Multiple SARS-CoV-2 Variants of Concern Demonstrated in K18-hACE2 Mouse and Syrian Golden Hamster Models
Dhanushkodi, N., Prakash, S., Quadiri, A., Zayou, L., Srivastava, R., Shaik, A. M., Suzer, B., Ibraim, I. C., Landucci, G., Tifrea, D. F., Singer, M., Jamal, L., Edwards, R. A., Vahed, H., Brown, L., BENMOHAMED, L.
10.1101/2023.06.07.544133 — Posted: 2023-06-08
Metformin reduces SARS-CoV-2 in a Phase 3 Randomized Placebo Controlled Clinical Trial
Bramante, C. T., Beckman, K. B., Mehta, T., Krager, A. B., Odde, D. J., Tignanelli, C. J., Buse, J. B., Johnson, D. M., Watson, R. H. B., Daniel, J. J., Liebovitz, D. M., Nicklas, J. M., Cohen, K., Puskarich, M. A., Belani, H. K., Siegel, L. K., Klatt, N. R., Anderson, B., Hartman, K. M., Rao, V., Hagan, A. A., Patel, B., Fenno, S. L., Avula, N., Reddy, N. V., Erickson, S. M., Fricton, R. D., Lee, S., Griffiths, G., Pullen, M. F., Thompson, J. L., Sherwood, N., Murray, T. A., Rose, M. R., Boulware, D. R., Huling, J. D.
10.1101/2023.06.06.23290989 — Posted: 2023-06-07
Impact of CoronaVac on Covid-19 outcomes of elderly adults in a large and socially unequal Brazilian city: A target trial emulation study
Monteiro, H. d. S., Neto, A. S. L., Kahn, R., Santos, G. S., Carmona, H. A., de Andrade, J. S., Castro, M. C.
10.1101/2023.06.06.23291015 — Posted: 2023-06-07
Estimating the effectiveness of COVID-19 vaccination against COVID-19 hospitalisation and death: a cohort study based on the 2021 Census, England.
Bermingham, C., Nafilyan, V., Andrews, N., Gethings, O.
10.1101/2023.06.06.23290982 — Posted: 2023-06-07
OpenSAFELY: The impact of COVID-19 on azathioprine, leflunomide, and methotrexate monitoring, and factors associated with change in monitoring rate.
The OpenSAFELY Collaborative, , Brown, A. D., Fisher, L., Curtis, H. J., Wiedemann, M., Hulme, W. J., Hopcroft, L. E., Cunningham, C., Speed, V., Costello, R. E., Galloway, J. B., Russell, M. D., Bechman, K., Kurt, Z., Croker, R., Wood, C., Walker, A. J., Schaffer, A. L., Bacon, S. C., Mehrkar, A., Hickman, G., Bates, C., Cockburn, J., Parry, J., Hester, F., Harper, S., Goldacre, B., MacKenna, B.
10.1101/2023.06.06.23290826 — Posted: 2023-06-07
Upper limb functional recovery in chronic stroke patients after COVID-19-interrupted rehabilitation: An observational study
Sakamoto, D., Hamaguchi, T., Nakayama, Y., Hada, T., Abo, M.
10.1101/2023.06.05.23290309 — Posted: 2023-06-07
Post-acute immunological and behavioral sequelae in mice after Omicron infection
Ma, T., Suryawanshi, R. K., Miller, S. R., Ly, K. K., Thomas, R., Elphick, N., Yin, K., Luo, X., Kaliss, N., Chen, I. P., Montano, M., Sreekumar, B., Standker, L., Munch, J., Damron, F. H., Palop, J. J., Ott, M., Roan, N. R.
10.1101/2023.06.05.543758 — Posted: 2023-06-07

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).